Aura Biosciences Cash Flow Statement (2020-2026) | AURA

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-8.80M-8.89M-11.63M-12.81M-13.82M-16.05M-17.61M-17.47M-18.30M-18.51M-22.13M-19.71M-20.34M-21.04M-25.21M-27.48M-27.02M-26.13M-25.55M-33.69M
Depreciation and Depletion (Quarter)
0.20M0.20M0.23M0.26M0.30M0.30M0.35M0.33M0.30M0.40M0.32M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.23M0.30M
Share-based Compensation (Quarter)
0.27M0.55M1.30M1.59M1.29M1.71M1.81M1.91M1.93M2.33M2.60M2.91M3.13M2.75M2.94M3.51M3.83M3.69M3.28M3.82M
Gains from Sales and Divestitures (Quarter)
0.05M0.04M0.09M0.14M0.20M0.31M0.21M0.32M0.38M0.53M0.50M
Gains from Investment Securities (Quarter)
0.00M1.88M0.09M4.28M-0.06M4.26M0.10M0.10M0.60M1.19M-0.18M4.11M6.05M0.98M0.49M1.43M0.29M0.19M0.05M
Non-cash Items (Quarter)
1.02M40.44M1.34M1.46M14.80M16.20M2.28M14.20M2.54M10.35M18.80M3.10M3.19M8.07M17.40M3.94M3.79M1.50M4.23M
Cash from Operations (Quarter)
-6.50M-8.69M-12.09M-15.20M-10.63M-10.76M-18.01M-16.41M-14.64M-15.40M-17.39M-24.45M-16.13M-15.27M-23.95M-23.36M-20.77M-20.14M-20.47M-29.89M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.20M0.20M0.23M0.26M0.30M0.30M0.35M0.33M0.30M0.40M0.32M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.23M0.30M
Change in Working Capital
Change in Account Payables (Quarter)
0.91M-0.72M0.16M-0.76M-0.76M0.84M1.02M-1.88M-0.50M0.89M0.46M0.02M-0.54M0.69M0.31M-0.30M-0.72M0.60M-0.43M1.02M
Change in Accured Expenses (Quarter)
0.53M1.11M0.85M-1.83M1.43M1.34M-0.70M-0.51M1.27M1.03M1.51M-2.90M1.35M3.14M-0.02M-2.48M3.38M3.35M-0.12M-2.75M
Other Working Capital Changes (Quarter)
-0.38M0.96M3.01M0.05M0.85M-1.39M3.75M-0.44M0.44M-1.32M3.75M-4.27M4.00M-4.27M-0.33M-0.33M-0.36M-3.02M-0.39M
Investing Activities
Capital Expenditures (Quarter)
0.08M1.15M0.82M0.60M-0.17M0.31M-0.56M0.01M0.29M-0.24M0.64M0.12M0.49M0.34M-0.92M0.19M0.04M0.04M0.18M0.02M
Change in Acquisitions & Divestments (Quarter)
18.00M32.01M22.08M21.60M21.72M55.00M99.18M30.00M30.00M30.00M30.00M30.00M55.00M
Cash from Investing Activities (Quarter)
-0.66M-0.57M-0.82M-25.50M-43.44M17.95M-16.88M-66.88M21.41M21.63M-90.12M9.40M19.84M9.89M29.70M29.81M19.98M-44.02M29.82M54.90M
Financing Activities
Other financing activities (Quarter)
0.29M1.14M-1.43M
Cash from Financing Activities (Quarter)
-0.26M-1.12M80.14M0.02M0.31M0.10M95.20M0.20M2.48M1.63M92.98M0.25M0.08M0.72M0.54M0.10M69.93M4.36M2.77M0.30M
Additional items
Exchange Rate Effect (Quarter)
-0.02M0.01M-0.01M-0.16M-0.03M
Change in Cash (Quarter)
-7.42M-10.38M67.24M-40.68M-53.76M7.29M60.31M-83.09M9.24M7.85M-14.52M-14.80M3.80M-4.67M6.29M6.55M69.13M-59.80M12.12M25.30M
Free Cash Flow (Quarter)
-6.58M-9.84M-12.90M-15.80M-10.46M-11.07M-17.46M-16.43M-14.93M-15.17M-18.03M-24.57M-16.62M-15.61M-23.03M-23.54M-20.81M-20.19M-20.64M-29.91M
Net Cash Flow (Quarter)
-7.42M-10.38M67.24M-40.68M-53.76M7.29M60.31M-83.09M9.24M7.85M-14.52M-14.80M3.80M-4.67M6.29M6.55M69.13M-59.80M12.12M25.30M